We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLACW
13401
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$37K ﹤0.01%
43,596
+8,196
+23% +$7.9K
AVCT
13402
CALL
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$37K ﹤0.01%
873
-2,547
-74% -$171K
EMX
13403
DELISTED
EMX Royalty
EMX
$36K ﹤0.01%
14,241
-12,023
-46% -$34.3K
ONCY
13404
Oncolytics Biotech
ONCY
$99.5M
$36K ﹤0.01%
16,988
-12,401
-42% -$28.1K
SYBX
13405
DELISTED
Synlogic
SYBX
$36K ﹤0.01%
802
-920
-53% -$43K
ACER
13406
PUT
DELISTED
Acer Therapeutics Inc
ACER
$36K ﹤0.01%
14,300
+3,000
+27% +$7.62K
TCACW
13407
DELISTED
Tuatara Capital Acquisition Corporation Warrant
TCACW
$36K ﹤0.01%
+65,739
New +$52K
EVFM
13408
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$36K ﹤0.01%
3,233
-3,074
-49% -$38.6K
HCCCW
13409
DELISTED
Healthcare Capital Corp. Warrant
HCCCW
$36K ﹤0.01%
52,256
-199,795
-79% -$143K
NGCAW
13410
DELISTED
NextGen Acquisition Corp. II Warrant
NGCAW
$36K ﹤0.01%
21,637
-197,113
-90% -$376K
CASI
13411
DELISTED
CASI Pharmaceuticals
CASI
$35K ﹤0.01%
+2,942
New +$39.8K
EVGN icon
13412
CALL
Evogene
EVGN
$9.49M
$35K ﹤0.01%
1,340
-11,130
-89% -$325K
SCLXW icon
13413
Scilex Holding Co Warrant
SCLXW
$35K ﹤0.01%
69,711
+5,385
+8% +$3.11K
RDGT
13414
Ridgetech Inc
RDGT
$3.01M
$35K ﹤0.01%
2
+1
+100% +$27.5K
AHG
13415
Akso Health Group
AHG
$1.09B
$34K ﹤0.01%
15,321
-9,955
-39% -$16.6K
CRBP icon
13416
PUT
Corbus Pharmaceuticals
CRBP
$195M
$34K ﹤0.01%
1,127
-4,683
-81% -$185K
EMX
13417
CALL
DELISTED
EMX Royalty
EMX
$34K ﹤0.01%
+13,200
New +$37.7K
NEXT icon
13418
PUT
NextDecade
NEXT
$1.91B
$34K ﹤0.01%
+12,100
New +$38.2K
PLAG icon
13419
Planet Green Holdings
PLAG
$12.8M
$34K ﹤0.01%
2,522
-1,081
-30% -$14.5K
PLX icon
13420
Protalix BioTherapeutics
PLX
$179M
$34K ﹤0.01%
24,945
-90,941
-78% -$138K
PULM icon
13421
Pulmatrix
PULM
$5.62M
$34K ﹤0.01%
+2,128
New +$35.5K
RGLS
13422
CALL
DELISTED
Regulus Therapeutics
RGLS
$34K ﹤0.01%
4,900
-2,690
-35% -$19.7K
SND icon
13423
CALL
Smart Sand
SND
$219M
$34K ﹤0.01%
13,700
-10,100
-42% -$25.9K
TMQ
13424
CALL
Trilogy Metals
TMQ
$646M
$34K ﹤0.01%
18,200
+200
+1% +$416
HCDI
13425
DELISTED
Harbor Custom Development, Inc. Common Stock
HCDI
$34K ﹤0.01%
+721
New +$41K

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.